|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,034.80 PKR | +2.71% |
|
+3.69% | +1.20% |
Projected Income Statement: Highnoon Laboratories Limited
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Net sales 1 | - | 27,706 | 30,398 | 34,163 | 38,399 |
| Change | - | - | 9.72% | 12.39% | 12.4% |
| EBITDA | - | - | - | - | - |
| Change | - | - | - | - | - |
| EBIT | - | - | - | - | - |
| Change | - | - | - | - | - |
| Interest Paid 1 | - | -130.9 | -159 | -149 | -149 |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Change | - | - | - | - | - |
| Net income | 3,389 | - | - | - | - |
| Change | - | - | - | - | - |
| Announcement Date | 3/26/25 | 4/7/26 | - | - | - |
1PKR in Million
Estimates
Forecast Balance Sheet: Highnoon Laboratories Limited
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Change | - | - | - | - | - |
| Announcement Date | 3/26/25 | 4/7/26 | - | - | - |
Estimates
Cash Flow Forecast: Highnoon Laboratories Limited
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| CAPEX 1 | 367.3 | 278.2 | 834.6 | 787.6 | 247.7 | 455 |
| Change | - | -24.27% | 200.04% | -5.63% | -68.55% | 83.67% |
| Free Cash Flow (FCF) 1 | 822.7 | 1,172 | -1,480 | 634.5 | 3,991 | 1,781 |
| Change | - | 42.49% | -226.23% | 142.88% | 528.98% | -55.38% |
| Announcement Date | 4/1/21 | 3/28/22 | 4/14/23 | 4/9/24 | 4/8/25 | 4/10/26 |
1PKR in Million
Estimates
Forecast Financial Ratios: Highnoon Laboratories Limited
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
| EBITDA Margin (%) | - | - | - | - | - | - | - | - | - |
| EBIT Margin (%) | - | - | - | - | - | - | - | - | - |
| EBT Margin (%) | - | - | - | - | - | - | - | - | - |
| Net margin (%) | - | - | - | - | - | - | - | - | - |
| FCF margin (%) | - | - | - | - | - | - | - | - | - |
| FCF / Net Income (%) | - | - | - | - | - | - | - | - | - |
Profitability | |||||||||
| ROA | - | - | - | - | - | 22.52% | 20% | 21% | 21% |
| ROE | - | - | - | - | - | 32.32% | 28% | 28% | 29% |
Financial Health | |||||||||
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - | - |
| Debt / Free cash flow | - | - | - | - | - | - | - | - | - |
Capital Intensity | |||||||||
| CAPEX / Current Assets (%) | - | - | - | - | - | - | - | - | - |
| CAPEX / EBITDA (%) | - | - | - | - | - | - | - | - | - |
| CAPEX / FCF (%) | - | - | - | - | - | - | - | - | - |
Items per share | |||||||||
| Cash flow per share 1 | - | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| Dividend per Share 1 | - | - | - | - | - | 50 | 45 | 52 | 60 |
| Change | - | - | - | - | - | - | -10% | 15.56% | 15.38% |
| Book Value Per Share 1 | - | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| EPS 1 | - | - | - | - | 63.95 | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | - | - | - | - | 52,983 | 52,983 | 52,983 | 52,983 | 52,983 |
| Announcement Date | - | - | - | - | 3/26/25 | 4/7/26 | - | - | - |
1PKR
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E | - | - |
| PBR | - | - |
| EV / Sales | 1.8x | 1.6x |
| Yield | 4.35% | 5.03% |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1,034.80PKR
Average target price
1,121.00PKR
Spread / Average Target
+8.33%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HINOON Stock
- Financials Highnoon Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
